Basic CYP inhibition risk table
basic_cyp_inhibition_risk_table.Rd
This function generates a markdown-formatted table of the direct (reversible)
CYP inhibition risk assessment. See basic_cyp_inhibition_risk()
for details
on the calculation of the risk.
Arguments
- perp
The perpetrator object.
- cyp_inh
CYP inhibition data as data frame. The following fields are expected:
'name' The name of the perpetrator compound.
'cyp' The CYP enzyme as (upper case) character.
'ki' The \(K_i\) in \(\mu M\) as numeric.
'source' Optional source information as character.
- na.rm
Switch to define whether rows with lacking \(K_i\) data are removed from the output (i.e., where
ki == NA
). Defaults toFALSE
.- show_dose
Show perpetrator dose in table title, defaults to
FALSE.
Examples
basic_cyp_inhibition_risk_table(examplinib_parent,
examplinib_cyp_inhibition_data)
#>
#>
#> Table: Risk for direct CYP inhibition by examplinib, basic model
#>
#> |CYP | $K_{i}$ ($\mu M$)| $K_{i,u}$ ($\mu M$)| $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) |
#> |:-------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------|
#> |CYP1A2 | NA| NA| NA| | | |
#> |CYP2B6 | NA| NA| NA| | | |
#> |CYP2C8 | 11.00| 11.00| 0.015|No | | |
#> |CYP2C9 | 0.60| 0.60| 0.275|Yes | | |
#> |CYP2C19 | 0.25| 0.25| 0.659|Yes | | |
#> |CYP2D6 | NA| NA| NA| | | |
#> |CYP3A4 | 12.50| 12.50| 0.013|No |292.3 |Yes |
basic_cyp_inhibition_risk_table(examplinib_compounds,
examplinib_cyp_inhibition_data, na.rm = TRUE)
#>
#>
#> Table: Risk for direct CYP inhibition by examplinib, basic model
#>
#> |CYP | $K_{i}$ ($\mu M$)| $K_{i,u}$ ($\mu M$)| $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) |
#> |:-------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------|
#> |CYP2C8 | 11.00| 11.00| 0.015|No | | |
#> |CYP2C9 | 0.60| 0.60| 0.275|Yes | | |
#> |CYP2C19 | 0.25| 0.25| 0.659|Yes | | |
#> |CYP3A4 | 12.50| 12.50| 0.013|No |292.3 |Yes |
#>
#>
#> Table: Risk for direct CYP inhibition by M1, basic model
#>
#> |CYP | $K_{i}$ ($\mu M$)| $K_{i,u}$ ($\mu M$)| $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) |
#> |:------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------|
#> |CYP2C9 | 4.4| 4.4| 0.006|No | | |
basic_cyp_inhibition_risk_table(examplinib_compounds,
examplinib_cyp_inhibition_data, na.rm = TRUE, show_dose = TRUE)
#>
#>
#> Table: Risk for direct CYP inhibition by examplinib (450 mg), basic model
#>
#> |CYP | $K_{i}$ ($\mu M$)| $K_{i,u}$ ($\mu M$)| $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) |
#> |:-------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------|
#> |CYP2C8 | 11.00| 11.00| 0.015|No | | |
#> |CYP2C9 | 0.60| 0.60| 0.275|Yes | | |
#> |CYP2C19 | 0.25| 0.25| 0.659|Yes | | |
#> |CYP3A4 | 12.50| 12.50| 0.013|No |292.3 |Yes |
#>
#>
#> Table: Risk for direct CYP inhibition by M1, basic model
#>
#> |CYP | $K_{i}$ ($\mu M$)| $K_{i,u}$ ($\mu M$)| $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) |
#> |:------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------|
#> |CYP2C9 | 4.4| 4.4| 0.006|No | | |